The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Open accessAbstract
As the second most common age related neurodegenerative disease after Alzheimer's disease, the health, social and economic impact resulting from Parkinson's disease will continue to increase alongside the longevity of the population. Ageing remains the biggest risk factor for developing idiopathic Parkinson's disease. Although research into the mechanisms leading to cell death in Parkinson's disease has shed light on many aspects of the pathogenesis of this disorder, we still cannot answer the fundamental question, what specific age related factors predispose some individuals to develop this common neurodegenerative disease. In this review we focus specifically on the neuronal population associated with the motor symptoms of Parkinson's disease, the dopaminergic neurons of the substantia nigra, and try to understand how ageing puts these neurons at risk to the extent that a slight change in protein metabolism or mitochondrial function can push the cells over the edge leading to catastrophic cell death and many of the symptoms seen in Parkinson's disease. We review the evidence that ageing is important for the development of Parkinson's disease and how age related decline leads to the loss of neurons within this disease, before describing exactly how advancing age may lead to substantia nigra neuronal loss and Parkinson's disease in some individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Mitofusin 2 tethers endoplasmic reticulum to mitochondria
de Brito, O. M., & Scorrano, L. (2008) · Nature · doi:10.1038/nature07534 · Cited by 2,442
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
α-Synuclein is phosphorylated in synucleinopathy lesions
Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. S., Shen, J., Takio, K., & Iwatsubo, T. (2002) · Nature Cell Biology · doi:10.1038/ncb748 · Cited by 2,132
Rubinsztein, D. C., Mariño, G., & Kroemer, G. (2011) · Cell · doi:10.1016/j.cell.2011.07.030 · Cited by 2,107
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570
Self-citationGiasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & -Y. Lee, V. M. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,546
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Devi, L., Raghavendran, V., Prabhu, B. M., Avadhani, N. G., & Anandatheerthavarada, H. K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710012200 · Cited by 1,080
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,037
‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
Chan, C. S., Guzman, J. N., Ilijic, E., Mercer, J. N., Rick, C., Tkatch, T., Meredith, G. E., & Surmeier, D. J. (2007) · Nature · doi:10.1038/nature05865 · Cited by 904
Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., Flint Beal, M., & Wallace, D. C. (1992) · Nature Genetics · doi:10.1038/ng1292-324 · Cited by 890
Kraytsberg, Y., Kudryavtseva, E., McKee, A. C., Geula, C., Kowall, N. W., & Khrapko, K. (2006) · Nature Genetics · doi:10.1038/ng1778 · Cited by 887
Murphy, D. D., Rueter, S. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-09-03214.2000 · Cited by 836
The pedunculopontine nucleus and Parkinson's disease
Pahapill, P. A. (2000) · Brain · doi:10.1093/brain/123.9.1767 · Cited by 831
Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
CENTRAL CERVICAL CORD SYNDROME AFTER HEADING A FOOTBALL
Scoppetta, C., & Vaccario, M. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92517-5 · Cited by 753
Martin, L. J., Pan, Y., Price, A. C., Sterling, W., Copeland, N. G., Jenkins, N. A., Price, D. L., & Lee, M. K. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4308-05.2006 · Cited by 684
Vogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683
α-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Proteasomal function is impaired in substantia nigra in Parkinson’s disease
McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01701-8 · Cited by 653
Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons
Ekstrand, M. I., Terzioglu, M., Galter, D., Zhu, S., Hofstetter, C., Lindqvist, E., Thams, S., Bergstrand, A., Hansson, F. S., Trifunovic, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605208103 · Cited by 605
Nakamura, K., Nemani, V. M., Azarbal, F., Skibinski, G., Levy, J. M., Egami, K., Munishkina, L., Zhang, J., Gardner, B., Wakabayashi, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213538 · Cited by 596
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
Sulzer, D. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.009 · Cited by 587
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Altered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
Alvarez-Erviti, L., Rodriguez-Oroz, M. C., Cooper, J. M., Caballero, C., Ferrer, I., Obeso, J. A., & Schapira, A. H. V. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.198 · Cited by 554
Hirsch, E. C., Graybiel, A. M., Duyckaerts, C., & Javoy-Agid, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5976 · Cited by 554
Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16983-3 · Cited by 548
Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease
van der Walt, J. M., Nicodemus, K. K., Martin, E. R., Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Haines, J. L., Koller, W. C., Lyons, K., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373937 · Cited by 537
Mitochondrial DNA mutations in human colonic crypt stem cells
Taylor, R. W., Barron, M. J., Borthwick, G. M., Gospel, A., Chinnery, P. F., Samuels, D. C., Taylor, G. A., Plusa, S. M., Needham, S. J., Greaves, L. C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19435 · Cited by 530
Self-citationSelective Increase of Iron in Substantia Nigra Zona Compacta of Parkinsonian Brains
Sofic, E., Paulus, W., Jellinger, K., Riederer, P., & Youdim, M. B. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02017.x · Cited by 524
Axonal mitochondrial transport and potential are correlated
Miller, K. E., & Sheetz, M. P. (2004) · Journal of Cell Science · doi:10.1242/jcs.01130 · Cited by 511
MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping
Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V., & Adalsteinsson, E. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2011.08.077 · Cited by 499
Tanaka, Y. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.9.919 · Cited by 497
Impaired Autophagosome Clearance Contributes to Cardiomyocyte Death in Ischemia/Reperfusion Injury
Ma, X., Liu, H., Foyil, S. R., Godar, R. J., Weinheimer, C. J., Hill, J. A., & Diwan, A. (2012) · Circulation · doi:10.1161/circulationaha.111.041814 · Cited by 491
The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo
Vincow, E. S., Merrihew, G., Thomas, R. E., Shulman, N. J., Beyer, R. P., MacCoss, M. J., & Pallanck, L. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221132110 · Cited by 478
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy
Thomas, K. J., McCoy, M. K., Blackinton, J., Beilina, A., van der Brug, M., Sandebring, A., Miller, D., Maric, D., Cedazo-Minguez, A., & Cookson, M. R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq430 · Cited by 454
Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain
Wei Soong, N., Hinton, D. R., Cortopassi, G., & Arnheim, N. (1992) · Nature Genetics · doi:10.1038/ng1292-318 · Cited by 414
Parkinson's Disease in a Chemist Working with 1-Methyl-4-Phenyl-L,2,5,6-Tetrahydropyridine
(1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090511 · Cited by 406
Reddy, P. H., Tripathi, R., Troung, Q., Tirumala, K., Reddy, T. P., Anekonda, V., Shirendeb, U. P., Calkins, M. J., Reddy, A. P., Mao, P., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.011 · Cited by 394
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis
Campbell, G. R., Ziabreva, I., Reeve, A. K., Krishnan, K. J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D. M., & Mahad, D. J. (2011) · Annals of Neurology · doi:10.1002/ana.22109 · Cited by 386
Self-citationWhat causes mitochondrial DNA deletions in human cells?
Krishnan, K. J., Reeve, A. K., Samuels, D. C., Chinnery, P. F., Blackwood, J. K., Taylor, R. W., Wanrooij, S., Spelbrink, J. N., Lightowlers, R. N., & Turnbull, D. M. (2008) · Nature Genetics · doi:10.1038/ng.f.94 · Cited by 380
Self-citationAlzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy
Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359
Pissadaki, E. K., & Bolam, J. P. (2013) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2013.00013 · Cited by 348
Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age
Elson, J. L., Samuels, D. C., Turnbull, D. M., & Chinnery, P. F. (2001) · The American Journal of Human Genetics · doi:10.1086/318801 · Cited by 340
Self-citationMitochondrial association of alpha-synuclein causes oxidative stress
Parihar, M. S., Parihar, A., Fujita, M., Hashimoto, M., & Ghafourifar, P. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7589-1 · Cited by 330
Bedford, L., Hay, D., Devoy, A., Paine, S., Powe, D. G., Seth, R., Gray, T., Topham, I., Fone, K., Rezvani, N., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2218-08.2008 · Cited by 327
Understanding the molecular causes of Parkinson's disease
Wood-Kaczmar, A., Gandhi, S., & Wood, N. W. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.09.007 · Cited by 327
Calì, T., Ottolini, D., Negro, A., & Brini, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302794 · Cited by 312
Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2
Mortiboys, H., Johansen, K. K., Aasly, J. O., & Bandmann, O. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ff9685 · Cited by 307
Sterky, F. H., Lee, S., Wibom, R., Olson, L., & Larsson, N.-G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103295108 · Cited by 299
α‐Synuclein oligomers and clinical implications for Parkinson disease
Kalia, L. V., Kalia, S. K., McLean, P. J., Lozano, A. M., & Lang, A. E. (2013) · Annals of Neurology · doi:10.1002/ana.23746 · Cited by 292
Weihofen, A., Thomas, K. J., Ostaszewski, B. L., Cookson, M. R., & Selkoe, D. J. (2009) · Biochemistry · doi:10.1021/bi8019178 · Cited by 290
Khaliq, Z. M., & Bean, B. P. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0143-10.2010 · Cited by 261
The role of the locus coeruleus in the development of Parkinson's disease
Gesi, M., Soldani, P., Giorgi, F. S., Santinami, A., Bonaccorsi, I., & Fornai, F. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00028-2 · Cited by 258
Zhou, C., Zhong, W., Zhou, J., Sheng, F., Fang, Z., Wei, Y., Chen, Y., Deng, X., Xia, B., & Lin, J. (2012) · Autophagy · doi:10.4161/auto.20284 · Cited by 253
Early‐onset familial parkinsonism due to POLG mutations
Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., & DiMauro, S. (2006) · Annals of Neurology · doi:10.1002/ana.20831 · Cited by 239
The role of alpha-synuclein in neurotransmission and synaptic plasticity
Cheng, F., Vivacqua, G., & Yu, S. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.12.001 · Cited by 237
Kastner, A., Hirsch, E. C., Lejeune, O., Javoy‐Agid, F., Rascol, O., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08350.x · Cited by 228
Cell-produced α-synuclein oligomers are targeted to, and impair, the 26S proteasome
Emmanouilidou, E., Stefanis, L., & Vekrellis, K. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.008 · Cited by 221
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M. I., Griffiths, F. M., Shepherd, C. E., & Double, K. L. (2005) · Brain · doi:10.1093/brain/awh584 · Cited by 219
Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction
Park, J., Kim, S. Y., Cha, G.-H., Lee, S. B., Kim, S., & Chung, J. (2005) · Gene · doi:10.1016/j.gene.2005.06.040 · Cited by 213
Nigral pathology and parkinsonian signs in elders without Parkinson disease
Buchman, A. S., Shulman, J. M., Nag, S., Leurgans, S. E., Arnold, S. E., Morris, M. C., Schneider, J. A., & Bennett, D. A. (2012) · Annals of Neurology · doi:10.1002/ana.22588 · Cited by 213
Wang, X., Petrie, T. G., Liu, Y., Liu, J., Fujioka, H., & Zhu, X. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07734.x · Cited by 207
Parihar, M. S., Parihar, A., Fujita, M., Hashimoto, M., & Ghafourifar, P. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.05.008 · Cited by 206
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Rodriguez-Oroz, M. C., Obeso, J. A., & Cooper, J. M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.73 · Cited by 204
Ottolini, D., Cali, T., Negro, A., & Brini, M. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt068 · Cited by 201
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour.
Zecca, L., Tampellini, D., Gerlach, M., Riederer, P. F., Fariello, R. G., & Sulzer, D. L. (2001) · PubMed · doi:10.1136/mp.54.6.414 · Cited by 199
Nigral and extranigral pathology in Parkinson's disease.
Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198
Reddy, P. H., & Shirendeb, U. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.016 · Cited by 188
Lewy pathology and neurodegeneration in premotor Parkinson's disease
Del Tredici, K., & Braak, H. (2012) · Movement Disorders · doi:10.1002/mds.24921 · Cited by 185
Iron-binding characteristics of neuromelanin of the human substantia nigra
Double, K. L., Gerlach, M., Schünemann, V., Trautwein, A. X., Zecca, L., Gallorini, M., Youdim, M. B. H., Riederer, P., & Ben-Shachar, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00293-4 · Cited by 181
The PINK1–Parkin pathway is involved in the regulation of mitochondrial remodeling process
Park, J., Lee, G., & Chung, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.11.086 · Cited by 180
The comparative biology of neuromelanin and lipofuscin in the human brain
Double, K. L., Dedov, V. N., Fedorow, H., Kettle, E., Halliday, G. M., Garner, B., & Brunk, U. T. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7581-9 · Cited by 179
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD
Pyle, A., Foltynie, T., Tiangyou, W., Lambert, C., Keers, S. M., Allcock, L. M., Davison, J., Lewis, S. J., Perry, R. H., Barker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20417 · Cited by 176
Mitofusin 2 is necessary for striatal axonal projections of midbrain dopamine neurons
Lee, S., Sterky, F. H., Mourier, A., Terzioglu, M., Cullheim, S., Olson, L., & Larsson, N.-G. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds352 · Cited by 174
Morphometry of the human substantia nigra in ageing and Parkinson’s disease
Rudow, G., O’Brien, R., Savonenko, A. V., Resnick, S. M., Zonderman, A. B., Pletnikova, O., Marsh, L., Dawson, T. M., Crain, B. J., West, M. J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0352-8 · Cited by 171
Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease
Goldberg, J. A., Guzman, J. N., Estep, C. M., Ilijic, E., Kondapalli, J., Sanchez-Padilla, J., & Surmeier, D. J. (2012) · Nature Neuroscience · doi:10.1038/nn.3209 · Cited by 167
Gasser, T., Hardy, J., & Mizuno, Y. (2011) · Movement Disorders · doi:10.1002/mds.23637 · Cited by 166
α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei
Braak, E., Sandmann-Keil, D., Rüb, U., Gai, W. P., de Vos, R. A. I., Jansen Steur, E. N. H., Arai, K., & Braak, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000247 · Cited by 162
Leverenz, J. B., Hamilton, R. L., Tsuang, D. W., Schantz, A. M., Vavrek, D. A., Larson, E. B., Kukull, W. A., López, O. L., Galasko, D. R., Masliah, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00117.x · Cited by 159
Verburg, J., & Hollenbeck, P. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2614-08.2008 · Cited by 152
Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease
Hudson, G., Nalls, M. A., Evans, J., Breen, D. P., Winder‐Rhodes, S., Morrison, K. E., Morris, H. R., Williams‐Gray, C. H., Barker, R. A., Singleton, A., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e318294b434 · Cited by 147
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra
Ma, S., Ciliax, B. J., Stebbins, G. T., Jaffar, S., Joyce, J. N., Cochran, E. J., Kordower, J. H., Mash, D. C., Levey, A. I., & Mufson, E. J. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990621)409:1<25::aid-cne3>3.0.co;2-e · Cited by 145
Simon, D. K., Pulst, S. M., Sutton, J. P., Browne, S. E., Beal, M. F., & Johns, D. R. (1999) · Neurology · doi:10.1212/wnl.53.8.1787 · Cited by 141
Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing
Ma, Röytt, Collan, & Rinne (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00202.x · Cited by 136
Shima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135
Haacke, E. M., Miao, Y., Liu, M., Habib, C. A., Katkuri, Y., Liu, T., Yang, Z., Lang, Z., Hu, J., & Wu, J. (2010) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22293 · Cited by 133
Pickrell, A. M., Pinto, M., Hida, A., & Moraes, C. T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4871-11.2011 · Cited by 128
Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
Maingay, M., Romero‐Ramos, M., Carta, M., & Kirik, D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.007 · Cited by 128
Proteasomal dysfunction in aging and Huntington disease
Li, X., & Li, S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.11.018 · Cited by 122
Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations
Abramov, A. Y., Smulders-Srinivasan, T. K., Kirby, D. M., Acín‐Pérez, R., Enríquez, J. A., Lightowlers, R. N., Duchen, M. R., & Turnbull, D. M. (2010) · Brain · doi:10.1093/brain/awq015 · Cited by 122
Self-citationBotella, J., Bayersdorfer, F., & Schneuwly, S. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.013 · Cited by 110
Age-related differences in iron content of subcortical nuclei observed in vivo: A meta-analysis
Daugherty, A. M., & Raz, N. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.12.040 · Cited by 110
Cerebellar Ataxia in Patients With Mitochondrial DNA Disease: A Molecular Clinicopathological Study
Lax, N. Z., Hepplewhite, P. D., Reeve, A. K., Nesbitt, V., McFarland, R., Jaros, E., Taylor, R. W., & Turnbull, D. M. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318244477d · Cited by 105
Self-citationDugger, B. N., Murray, M. E., Boeve, B. F., Parisi, J. E., Benarroch, E. E., Ferman, T. J., & Dickson, D. W. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01203.x · Cited by 102
Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population
Huerta, C., Castro, M. G., Coto, E., Estrada, M. B., Ribacoba, R., Guisasola, L. M., Salvador, C., Martínez, C., Lahoz, C. H., & Álvarez, V. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.04.016 · Cited by 96
Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease
Krishnan, K. J., Ratnaike, T. E., De Gruyter, H. L. M., Jaros, E., & Turnbull, D. M. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.009 · Cited by 95
Self-citationThe Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons
Reeve, A. K., Meagher, M., Lax, N., Simcox, E. M., Hepplewhite, P. D., Jaros, E., & Turnbull, D. M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3525-12.2013 · Cited by 94
Self-citationA Novel Polymerase γ Mutation in a Family With Ophthalmoplegia, Neuropathy, and Parkinsonism
Mancuso, M., Filosto, M., Oh, S. J., & DiMauro, S. (2004) · Archives of Neurology · doi:10.1001/archneur.61.11.1777 · Cited by 92
Arnold, B. A., Cassady, S. J., Laar, V. S. V., & Berman, S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.006 · Cited by 89
Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions
Bender, A., Schwarzkopf, R.-M., McMillan, A., Krishnan, K. J., Rieder, G., Neumann, M., Elstner, M., Turnbull, D. M., & Klopstock, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0892-9 · Cited by 89
Self-citationHudson, G., Schaefer, A. M., Taylor, R. W., Tiangyou, W., Gibson, A., Venables, G. S., Griffiths, P. G., Burn, D. J., Turnbull, D. M., & Chinnery, P. F. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.553 · Cited by 87
Self-citationEvidence for specific phases in the development of human neuromelanin
Fedorow, H., Halliday, G. M., Rickert, C. H., Gerlach, M., Riederer, P. F., & Double, K. L. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.02.015 · Cited by 83
α-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability
Chen, Q., Thorpe, J. A., & Keller, J. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501308200 · Cited by 81
Perier, C., Bender, A., García‐Arumí, E., Melia, M., Bové, J., Laub, C., Klopstock, T., Elstner, M., Mounsey, R. B., Teismann, P., et al. (2013) · Brain · doi:10.1093/brain/awt196 · Cited by 78
The pathology roadmap in Parkinson disease
Surmeier, D. J., & Sulzer, D. (2013) · Prion · doi:10.4161/pri.23582 · Cited by 74
Cytochrome c oxidase defects of the human substantia nigra in normal aging
Itoh, K., Weis, S., Mehraein, P., & Müller‐Höcker, J. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00168-6 · Cited by 72
Protein homeostasis and aging: Role of ubiquitin protein ligases
Jana, N. R. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.02.009 · Cited by 67
Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNA Lys
Horváth, R., Kley, R. A., Lochmüller, H., & Vorgerd, M. (2007) · Neurology · doi:10.1212/01.wnl.0000250334.48038.7a · Cited by 67
Evidence for specific phases in the development of human neuromelanin
Halliday, G. M., Fedorow, H., Rickert, C. H., Gerlach, M., Riederer, P. F., & Double, K. L. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0449-y · Cited by 65
Morphological alterations of the synapses in the locus coeruleus in Parkinson's disease
Balogiannis, S., Costa, V., & Baloyannis, I. S. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.006 · Cited by 59
HtrA2/Omi deficiency causes damage and mutation of mitochondrial DNA
Goo, H., Jung, M. K., Han, S. S., Rhim, H., & Kang, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.03.016 · Cited by 58
POLG1 polyglutamine tract variants associated with Parkinson's disease
Eerola, J., Luoma, P. T., Peuralinna, T., Scholz, S. W., Paisán‐Ruiz, C., Suomalainen, A., Singleton, A., & Tienari, P. J. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.021 · Cited by 54
Mitochondrial DNA deletions inhibit proteasomal activity and stimulate an autophagic transcript
Alemi, M., Prigione, A., Wong, A., Schoenfeld, R., DiMauro, S., Hirano, M., Taroni, F., & Cortopassi, G. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.09.014 · Cited by 50
Elstner, M., Müller, S. K., Leidolt, L., Laub, C., Krieg, L., Schlaudraff, F., Liss, B., Morris, C. M., Turnbull, D. M., Masliah, E., et al. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-43 · Cited by 50
Self-citationRelationship Between Mitochondria and α-Synuclein
Reeve, A. K. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2675 · Cited by 49
Self-citationBetts, J., Jaros, E., Krishnan, K. J., Perry, R. H., Reeve, A. K., Schaefer, A. M., Taylor, R. W., & Turnbull, D. M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00981.x · Cited by 45
Self-citationMitochondrial DNA mutations affect calcium handling in differentiated neurons
Trevelyan, A. J., Kirby, D. M., Smulders-Srinivasan, T. K., Nooteboom, M., Acín‐Pérez, R., Enríquez, J. A., Whittington, M. A., Lightowlers, R. N., & Turnbull, D. M. (2010) · Brain · doi:10.1093/brain/awq023 · Cited by 42
Self-citationMitochondrial myopathy, parkinsonism, and multiple mtDNA deletions in a Sephardic Jewish family
Casali, C., Bonifati, V., Santorelli, F. M., Casari, G., Fortini, D., Patrignani, A., Fabbrini, G., Carrozzo, R., d’Amati, G., Locuratolo, N., et al. (2001) · Neurology · doi:10.1212/wnl.56.6.802 · Cited by 41
Song, L., Shan, Y., Lloyd, K. C. K., & Cortopassi, G. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds365 · Cited by 39
Mitochondrial DNA rearrangements in young onset parkinsonism: two case reports
Siciliano, G. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.5.685 · Cited by 38
Anvret, A., Westerlund, M., Sydow, O., Willows, T., Lind, C., Galter, D., & Belin, A. C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.08.082 · Cited by 34
Latsoudis, H., Spanaki, C., Chlouverakis, G., & Plaitakis, A. (2008) · Journal of Human Genetics · doi:10.1007/s10038-008-0259-1 · Cited by 32
Balafkan, N., Tzoulis, C., Müller, B., Haugarvoll, K., Tysnes, O., Larsen, J. P., & Bindoff, L. A. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.08.004 · Cited by 30
Reeve, A. K., Krishnan, K. J., Taylor, G. A., Elson, J. L., Bender, A., Taylor, R. W., Morris, C. M., & Turnbull, D. M. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00492.x · Cited by 29
Self-citationIron as a trigger of neurodegeneration in Parkinson's disease
Friedman, A., Gałązka-Friedman, J., & Bauminger, E. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83023-5 · Cited by 18
Neuropathology of dementia with Lewy bodies
Lowe, J. S. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01231-6 · Cited by 14
Neocortical neuron number in humans: Effect of sex and age
(1997) · doi:10.1002/(sici)1096-9861(19970728)384:2<312::aid-cne10>3.0.co;2-k
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Trist, B. G., Hare, D. J., & Double, K. L. (2019) · Aging Cell · doi:10.1111/acel.13031 · Cited by 778
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes
Etchegaray, J.-P., & Mostoslavsky, R. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.029 · Cited by 518
Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease
Nissanka, N., & Moraes, C. T. (2018) · FEBS Letters · doi:10.1002/1873-3468.12956 · Cited by 444
Metadata
- Authors
- Reeve, A., Simcox, E., & Turnbull, D.
- Venue
- Ageing Research Reviews
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 14
- Pages
- 19-30
- ISSN
- 1568-1637 (ISSN-L)
- OpenAlex
- W2142430469
- Cited by
- 947
- References
- 143
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.